Modulating T Follicular Cells In Vivo Enhances Antigen-Specific Humoral Immunity

Key Points Extended ABX treatment yielded higher affinity IgG following immunization. Extended ABX treatment resulted in enhanced pathology in a nephrotoxic nephritis model. PD-1 blockade phenocopied extended ABX following immunizations. Generation of high-affinity IgG is essential for defense against infections and cancer, which is the intended consequence of many vaccines, but can cause autoimmune and inflammatory diseases when inappropriately directed against self. The interplay of T follicular helper (TFH) cells and T follicular regulatory (TFR) cells is critical for the production of high-affinity IgG of a specific subclass. In this study, we sought to improve Ag-specific IgG responses with two interventions intended to transiently diminish TFR cell influence. First, adult mice were administered an antibiotic mixture (ABX) for an extended period to deplete the immunoregulatory intestinal microbiota. This intriguingly increased TFH cell and reduced TFR cell numbers. 2,4,6-Trinitrophenyl hapten conjugated to keyhole limpet hemocyanin immunization resulted in higher affinity 2,4,6-trinitrophenyl hapten–specific IgG1 in ABX mice compared with controls. In a model of IgG-driven inflammatory nephritis, ABX mice had significantly worse nephritis accompanied by higher affinity Ag-specific IgG2b and enriched TFH cells compared with controls. Second, we sought to functionally manipulate TFH and TFR cells, which both express the checkpoint inhibitory molecule, PD-1, by administration of anti–PD-1 during immunization. This intervention enhanced the affinity of Ag-specific IgG of the appropriate subclass and increased in TFH cells following 2,4,6-trinitrophenyl hapten conjugated to keyhole limpet hemocyanin immunization and nephritis induction. These results suggest that altering TFH and TFR cell ratios during immunization is an appealing strategy to qualitatively improve Ag- and subclass-specific IgG responses.

[1]  V. Beneš,et al.  Tetracycline Antibiotics Induce Host-Dependent Disease Tolerance to Infection , 2020, Immunity.

[2]  E. Compeer,et al.  Antibody response to SARS-CoV-2 — sustained after all? , 2020, Nature Reviews Immunology.

[3]  Victor Greiff,et al.  Mucosal or systemic microbiota exposures shape the B cell repertoire , 2020, Nature.

[4]  Yuquan Wei,et al.  A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity , 2020, Nature.

[5]  K. Takeda,et al.  Microbiota-derived butyrate limits the autoimmune response by promoting the differentiation of follicular regulatory T cells , 2020, EBioMedicine.

[6]  C. Rice,et al.  Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals , 2020, Nature.

[7]  Julie Joseph,et al.  Divergent T follicular helper cell requirement for IgA and IgE production to peanut during allergic sensitization , 2020, Science Immunology.

[8]  A. Yoshimura,et al.  E4BP4-mediated inhibition of T follicular helper cells is compromised in autoimmune disease. , 2020, The Journal of clinical investigation.

[9]  B. Lambrecht,et al.  Ribosome-Targeting Antibiotics Impair T Cell Effector Function and Ameliorate Autoimmunity by Blocking Mitochondrial Protein Synthesis , 2019, bioRxiv.

[10]  D. Pe’er,et al.  Combination anti–CTLA-4 plus anti–PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies , 2019, Proceedings of the National Academy of Sciences.

[11]  B. Pulendran,et al.  Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans , 2019, Cell.

[12]  W. Flynn,et al.  Identification of a T follicular helper cell subset that drives anaphylactic IgE , 2019, Science.

[13]  William A. Walters,et al.  Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2 , 2019, Nature Biotechnology.

[14]  N. Curtis,et al.  Factors That Influence the Immune Response to Vaccination , 2019, Clinical Microbiology Reviews.

[15]  D. Neuberg,et al.  Microbial symbionts regulate the primary Ig repertoire , 2018, The Journal of experimental medicine.

[16]  Benjamin D. Kaehler,et al.  Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2’s q2-feature-classifier plugin , 2018, Microbiome.

[17]  Kelsey K. Finn,et al.  B Cells Drive Autoimmunity in Mice with CD28-Deficient Regulatory T Cells , 2017, The Journal of Immunology.

[18]  Dana Pe’er,et al.  Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade , 2017, Cell.

[19]  C. Mackay,et al.  Metabolite-Sensing G Protein-Coupled Receptors-Facilitators of Diet-Related Immune Regulation. , 2017, Annual review of immunology.

[20]  Y. Belkaid,et al.  Homeostatic Immunity and the Microbiota. , 2017, Immunity.

[21]  James L. Richards,et al.  Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes , 2017, Nature Immunology.

[22]  K. Honda,et al.  The microbiota in adaptive immune homeostasis and disease , 2016, Nature.

[23]  W. Garrett,et al.  Gut microbiota, metabolites and host immunity , 2016, Nature Reviews Immunology.

[24]  Hong Liu,et al.  Follicular regulatory T cells repress cytokine production by follicular helper T cells and optimize IgG responses in mice , 2016, European journal of immunology.

[25]  Paul J. McMurdie,et al.  DADA2: High resolution sample inference from Illumina amplicon data , 2016, Nature Methods.

[26]  A. Sharpe,et al.  T follicular regulatory cells in the regulation of B cell responses. , 2015, Trends in immunology.

[27]  A. Melnick,et al.  BCL6 orchestrates Tfh cell differentiation via multiple distinct mechanisms , 2015, The Journal of experimental medicine.

[28]  Maxim N. Artyomov,et al.  Checkpoint Blockade Cancer Immunotherapy Targets Tumour-Specific Mutant Antigens , 2014, Nature.

[29]  S. Crotty T follicular helper cell differentiation, function, and roles in disease. , 2014, Immunity.

[30]  A. Mamalis,et al.  Targeting the PD-1 pathway: a promising future for the treatment of melanoma , 2014, Archives of Dermatological Research.

[31]  W. Jefferies,et al.  Faculty Opinions recommendation of Microbial colonization influences early B-lineage development in the gut lamina propria. , 2013 .

[32]  T. Kepler,et al.  Microbial colonization influences early B-lineage development in the gut lamina propria , 2013, Nature.

[33]  Susan Holmes,et al.  phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data , 2013, PloS one.

[34]  F. Bäckhed,et al.  The gut microbiota — masters of host development and physiology , 2013, Nature Reviews Microbiology.

[35]  Loise M. Francisco,et al.  The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood , 2012, Nature Immunology.

[36]  William A. Walters,et al.  Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms , 2012, The ISME Journal.

[37]  Tim F. Rayner,et al.  Foxp3+ follicular regulatory T cells control T follicular helper cells and the germinal center response , 2011, Nature Medicine.

[38]  R. Knight,et al.  Moving pictures of the human microbiome , 2011, Genome Biology.

[39]  Marcel Martin Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .

[40]  S. Crotty,et al.  Follicular helper CD4 T cells (TFH). , 2011, Annual review of immunology.

[41]  K. Honda,et al.  Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species , 2011, Science.

[42]  A. Rudensky,et al.  A critical role for regulatory T cell–mediated control of inflammation in the absence of commensal microbiota , 2010, The Journal of experimental medicine.

[43]  William A. Walters,et al.  Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample , 2010, Proceedings of the National Academy of Sciences.

[44]  L. Cavacini,et al.  Structure and function of immunoglobulins. , 2010, The Journal of allergy and clinical immunology.

[45]  R. Xavier,et al.  Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 , 2009, Nature.

[46]  J. Ravetch,et al.  Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation , 2006, Science.

[47]  M. Madaio,et al.  The Journal of Experimental Medicine CORRESPONDENCE , 2005 .

[48]  T. Honjo,et al.  PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells. , 2004, International immunology.

[49]  F. Shokri,et al.  Measurement of Affinity Constant of Anti-human IgG Monoclonal Antibodies by an ELISA-based Method , 2004 .

[50]  Ruslan Medzhitov,et al.  Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.

[51]  Yoshimasa Tanaka,et al.  Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[52]  T. Okazaki,et al.  Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. , 2001, Science.

[53]  G. Freeman,et al.  Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation , 2000, The Journal of experimental medicine.

[54]  K. Rajewsky,et al.  From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. , 1999, Immunity.

[55]  T. Honjo,et al.  Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. , 1998, International immunology.

[56]  T. Honjo,et al.  Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. , 1996, International immunology.

[57]  J. Allison,et al.  Enhancement of Antitumor Immunity by CTLA-4 Blockade , 1996, Science.

[58]  T. Honjo,et al.  Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. , 1992, The EMBO journal.

[59]  J. Ravetch,et al.  Fcγ receptors as regulators of immune responses , 2008, Nature Reviews Immunology.

[60]  J. Ravetch,et al.  Fcgamma receptors as regulators of immune responses. , 2008, Nature reviews. Immunology.

[61]  Sang Joon Kim,et al.  A Mathematical Theory of Communication , 2006 .

[62]  J. V. Ravetch,et al.  IgG Fc receptors. , 2001, Annual review of immunology.

[63]  D. Salant,et al.  [38] Experimental glomerulonephritis , 1988 .